SFI
BIOR

Susquehanna Fundamental Investments’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Susquehanna Fundamental Investments’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-394
Closed -$150K – 1848
2021
Q3 		$150K Buy
394
+138
+54% +$59.2K ﹤0.01% 1582
2021
Q2 		$228K Buy
+256
New +$196K ﹤0.01% 1448

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna Fundamental Investments's BIOR Position: Q4 2021 in Review

Susquehanna Fundamental Investments sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2021, closing a stake of 394 shares — an estimated $150K sold.

Susquehanna Fundamental Investments first reported a position in BIOR in Q2 2021 and held it in 2 quarters. The position peaked at $228K in Q2 2021. 53 funds tracked by Wall St. Rank hold BIOR as of Q4 2021.

  • Susquehanna Fundamental Investments reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 394 Biora Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $150K.
  • Susquehanna Fundamental Investments first reported a position in Biora Therapeutics, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Susquehanna Fundamental Investments's Biora Therapeutics, Inc. Common Stock position peaked at $228K in Q2 2021.
  • 53 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2021, filed 14 Feb 2022.